Lumenis Surgical
Gastroenterology
Gastroenterology

Expanding Your Reach in Gastroenterology

Our Gastroenterology products are highly effective for therapeutic and palliative management of stones, malignant tumors and benign strictures, delivering precise ablation, vaporization, incision, excision and coagulation of highly targeted areas with minimal thermal effect to surrounding areas.

The SlimLine SIS GI is the first fiber designed specifically for GI procedures. A patented fiber tip design facilitates laser technology through the cholangioscope.

• Long enough to reach the bile duct
• Passes easily through tight turns in the scope
• Advances to the operative site with the scope in position

GASTROENTEROLOGY APPLICATIONS
Stone
Management
  Effective on all stone types, including pigmented and calcium stones, bile duct stones, pancreatic duct stones and large impacted stones.

A 97.3% bile duct stone clearance rate has been reported with the VersaPulse holmium laser and SlimLine GI fiber.
Malignant Neoplasm
  Effectively treats benign and malignant neoplasms, including, Cholangio carcinoma, Duodenal Cancer, and Esophageal tumors.

Benign Stricture

  Effective for a wide range of strictures, including Biliary, Esophageal and Colonic Strictures.
 * Holmium-YAG Laser Lithotripsy in the Treatment of Pancreaticobiliary Calculi Utilizing Peroral Single Operator Cholangioscopy (SpyGlass®): An Update on a Multi-Center Experience; Dr. Sandeep Patel, The University of Texas Health Science Center at San Antonio, TX; Presentation
given at DDW 2010.

PB-1004690 ver A

  Products for Gastroenterology Applications:
VersaPulse PowerSuite 100W
VersaPulse PowerSuite 80/100W
VersaPulse PowerSuite 60W
VersaPulse P20
Holmium Accessories

 

  Product Literature PDFs
VersaPulse Laser Systems
VersaPulse P20
Holmium Fibers

 

  Related Clinical Experience
Lumenis Clinical Information

 

  Product Literature
SlimLine SIS GI Fiber Datasheet
eSeminar: Ho:YAG Lithotripsy

 


©2014 Lumenis Surgical | Terms of Use | Legal Notice | Privacy Statement | Trademarks | Corporate